136 related articles for article (PubMed ID: 2584397)
41. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index.
Puccioni-Sohler M; Rios M; Carvalho SM; Gonçalves RR; Oliveira C; Correa RB; Novis S; de Oliveira MS; Bianco C
Neurology; 2001 Aug; 57(4):725-7. PubMed ID: 11524492
[TBL] [Abstract][Full Text] [Related]
43. Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Makino M; Azuma M; Wakamatsu SI; Suruga Y; Izumo S; Yokoyama MM; Baba M
Clin Diagn Lab Immunol; 1999 May; 6(3):316-22. PubMed ID: 10225829
[TBL] [Abstract][Full Text] [Related]
44. HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings.
Puccioni-Sohler M; Kitze B; Felgenhauer K
Arq Neuropsiquiatr; 1995 Jun; 53(2):213-7. PubMed ID: 7487526
[TBL] [Abstract][Full Text] [Related]
45. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
[TBL] [Abstract][Full Text] [Related]
46. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
47. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
[TBL] [Abstract][Full Text] [Related]
48. Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP.
Guerra M; Luna T; Souza A; Amorim C; Carvalho NB; Carvalho L; Tanajura D; Cardoso LS; Carvalho EM; Santos S
Cell Immunol; 2018 Dec; 334():70-77. PubMed ID: 30473006
[TBL] [Abstract][Full Text] [Related]
49. Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP).
Nagai M; Ijichi S; Hall WW; Osame M
Clin Immunol Immunopathol; 1995 Dec; 77(3):324-31. PubMed ID: 7586743
[TBL] [Abstract][Full Text] [Related]
50. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
52. Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTLV-I) associated myelopathy.
Shibayama K; Nakamura T; Kinoshita I; Ueki Y; Nakao H; Eguchi K; Tsujihata M; Nagataki S
Intern Med; 1992 Sep; 31(9):1081-3. PubMed ID: 1358283
[TBL] [Abstract][Full Text] [Related]
53. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
[TBL] [Abstract][Full Text] [Related]
54. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
[TBL] [Abstract][Full Text] [Related]
55. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary involvement in patients with human T lymphotropic virus type 1-associated myelopathy: the presence of specific IgA antibody in bronchoalveolar lavage fluid.
Sugimoto M; Imamura F; Matsumoto M; Sonoda E; Cho I; Ando M
Am J Trop Med Hyg; 1993 Jun; 48(6):803-11. PubMed ID: 8333573
[TBL] [Abstract][Full Text] [Related]
57. Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis.
Gessain A; Saal F; Giron ML; Lasneret J; Lagaye S; Gout O; De Thé G; Sigaux F; Peries J
J Gen Virol; 1990 Feb; 71 ( Pt 2)():333-41. PubMed ID: 2307964
[TBL] [Abstract][Full Text] [Related]
58. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
59. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
[TBL] [Abstract][Full Text] [Related]
60. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Ohta M; Ohta K; Nishimura M; Saida T
Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
